Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot suits help seniors recover from hip fractures

NCT ID NCT07323147

Symptom relief Sponsor: Hai bao Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a wearable robot suit can help people aged 65 and older recover leg function after hip fracture surgery. Participants will either do standard rehab or use the robot suit during therapy. The goal is to see if the robot improves walking, balance, and pain better than traditional methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 86 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 65 years or older, regardless of gender. * Diagnosed with a unilateral hip fracture resulting from low-energy trauma by imaging (X-ray/CT), and having undergone surgical treatment (internal fixation or arthroplasty). * The participant or their legal guardian understands and agrees to participate in the clinical trial and is willing to provide voluntary written informed consent. Exclusion Criteria: * Life expectancy of less than 6 months. * History of neurological disorders such as prior stroke, spinal cord injury, Parkinson's disease, or myasthenia gravis. * Severe joint contractures, deformities, or heterotopic ossification in the lower limbs that would prevent proper device fitting. * Body weight exceeding the device's maximum load capacity (\>100 kg). * Height outside the adjustable range of the device. * Presence of a pathological fracture or multiple fragility fractures. * Presence of severe osteoarthritis or trauma in the contralateral lower limb that significantly impairs function. * Comorbidities including active malignancy or systemic infection. * Comorbidities such as thromboembolic disease in the lower limbs, pneumonia, or pressure injuries (bedsores). * Comorbidities affecting rehabilitation capacity, including unstable angina, heart failure, severe sequelae of stroke, severe chronic obstructive pulmonary disease (COPD), or severe hepatic/renal dysfunction. * Poor compliance, cognitive impairment preventing cooperation, or diagnosed psychiatric disorders such as depression or anxiety. * Participation in any other clinical trial within the 3 months prior to screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gait disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture Mobility Limitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gait disorders Geriatrics Hip fracture Lower extremity dysfunction Postoperative rehabilitation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Beijing Jishuitan Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100035, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.